Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Cluster 4/5 was treated with the dual ICI regimen of ipilimumab plus nivolumab. This arm remains open to accrual. Clusters 3, 6, and 7 were excluded from the study. Additional secondary endpoints are ...

The presence of Tau and TDP-43 co-aggregates is associated with high Alzheimer’s disease (AD) severity, but whether there is ...

CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key ...

Community-acquired pneumonia is a major global health challenge that disproportionately affects vulnerable populations, ...

Mars is closer than ever, but the human body isn’t ready. Inside the biological war against radiation, microgravity, and ...

今日与大家汇报原发性纤毛运动障碍（PCD）的进展，我认为对我们未来的工作有所帮助和启发。一、PCD的定义及诊断流程首先看PCD的定义，它强调以支气管扩张为主的呼吸道表现。它是因为先天性的纤毛结构或功能异常，或者多运动纤毛生成减少，导致的呼吸道黏液清除 ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.